Think Research Corporation launched earlier this year a SaaS-based Learning Management System that has been selected by a global pharmaceutical company as a bolt-on white-label education platform to support continually evolving pharmacist and physician online pharma education and training. In addition to the LMS news, MDBriefCase, a Think Research company, and leading global provider of accredited online continuing medical education is leveraging expertise in oncology to expand education and training partnerships in the field, including new partnerships with the Canadian Association of Radiation Oncology (CARO) and Women in Cancer/All in Cancer (WinC-AlinC). Additionally, MDBriefCase is extending its education and training expertise into new value-added specialty areas, expanding into the field of neurology through a new strategic partnership with the Canadian League Against epilepsy (CLAE).

As academic partners, MDBriefCase and CLAE are co-developing a series of educational modules addressing current challenges facing clinicians in the treatment and management of epilepsy, slated for launch in 2024.